The Science of Ouchie Powder
Ouchie Powder is a disaccharide sugar known as β-D-galactopyranosyl-(1→4)-D-glucose.
It is a naturally derived dairy by-product that has been refined into soft, fine, talc-like powder. The dairy product from which Ouchie Powder is derived is sourced from cows raised in one of the most pristine environments on earth. These picturesque pastures in New Zealand are untouched by the overcrowded and over-polluted cities where the vast majority of commercial wound management products are manufactured.
How does it work?
The ability of an individual’s body to coagulate blood and repair tissue can be affected by numerous factors such as infection, metabolic deficiencies such as diabetes, venous or arterial disease and variations in wound structure such as depth, size and wound location.
These healing factors have been perfectly addressed with Ouchie Powder. Wound location, wound shape and infection are addressed by Ouchie Powder's ability to cover any shape or sized wound no matter where on the body it is located. The natural antibiotic properties of Ouchie Powder work to prevent infection while absorbing excess blood and instigating fast coagulation.
Ouchie Powder works to activate the coagulation cascade, stimulating blood platelets into forming an aggregated mesh of cross-linked fibrin proteins to form a clot and stop bleeding. The process is referred to as fibroplasia and Ouchie Powder has been proven to accelerate the healing process by stimulating fibroblast cells to enter the wound site and begin laying down an extracellular matrix of collagens, glycosaminoglycan, reticular and elastic fibres and glycoproteins which form the fundamental building blocks of skin repair.
Has the product been tested?
Independent scientific testing has been conducted by Trinity BioActives in New Zealand. Trinity Bioactives specialize in developing, testing and confirming the efficacy of human and animal nutraceuticals.
The testing on both human and animal skin cells was completed utilizing a modified TBL cell proliferative assay (SOP: TBL-XCP 7.0). Here, human skin fibroblasts were cultured to confluence in 24 well plates. Once confluence was attained, a circular wound was created (6mm in diameter) and the cells from within the ring were removed.
1mg of Ouchie Powder was applied to each plate and the reduced wound size was measured at 24, 48 and 72 hours. The results were as follows:
1mg of Ouchie Powder at 24 hours – Wound size reduction of 18.3%
1mg of Ouchie Powder at 48 hours – Wound size reduction of 89.4%
1mg of Ouchie Powder at 72 hours – Wound size reduction of 100%
All testing was completed in triplicate and tested against controls. The wound areas were measured both digitally and graphically. The results show a strong and significant promotion of wound closure and cell regeneration when compared to the untreated control which had not healed within the 72-hour time frame.
With live tissue culture proving the safety and efficacy of the product, Ouchie Powder was then tested on both animals and humans. Feedback provided from these test groups confirmed not only healing results replicated in the lab but also some surprising effects on other conditions such as rashes, headaches and acne treatment. The significant impact that Ouchie Powder has made on these and other conditions warrants further research and investigation and further testing will be conducted in the coming months to verify Ouchie Powders' applications beyond the scope of wound healing.